Skip to main content

Table 4 Left ventricular outcomes versus PDM/DM: Adjusted Model #2 (Reference = No PDM/DM)

From: Glycemic status, non-traditional risk and left ventricular structure and function in the Jackson Heart Study

Left Ventricular Measures Prediabetes Sig Diabetes Sig n
Mean difference Percent parameter difference (95% CI) Mean difference Percent parameter difference (95% CI)
Left Ventricular Ejection Fraction (%) 0.40 0.65 (− 0.58, 1.91) 0.302 − 0.14 − 0.233 (− 2.15, 1.72) 0.814 2082
Left Ventricular Fractional Shortening (%) − 0.68 − 1.75 (− 3.73, 0.28) 0.090 − 0.16 − 0.42 (− 3.60, 2.86) 0.798 1512
Left Ventricular End Diastolic Volume (ml/m2) − 1.15 − 2.82 (− 4.66, − 0.95) 0.003 − 0.66 − 1.23 (− 4.15, 1.77) 0.417 2082
Left Ventricular End Systolic Volume (ml/m2) − 0.62 − 3.73 (− 6.88, − 0.47) 0.025 − 0.04 − 0.27 (− 5.35, 5.08) 0.920 2082
Stroke Volume Index (ml/m2) − 0.87 − 2.36 (− 4.37, − 0.31) 0.024 − 0.71 − 1.92 (− 5.07, 1.33) 0.243 2082
Cardiac Index (L/min/m2) − 0.05 − 2.26 (− 4.53, 0.07) 0.058 0.12 5.10 (1.28, 9.07) 0.009 2082
Myocardial Contraction Fraction (%) − 0.04 − 0.81 (− 2.98, 1.40) 0.469 − 1.64 − 2.96 (− 6.25, 0.45) 0.089 2082
Left Ventricular Mass Index (g/m2)  < 0.01 0.01 (− 2.14, 2.21) 0.997 2.68 3.28 (− 0.19, 6.88) 0.064 2082
Relative Wall Thickness (cm) 0.01 1.54 (− 0.23, 3.35) 0.089 0.01 2.63 (− 0.16, 5.50) 0.065 2082
  1. Each row represents a separate model for Left ventricular outcomes and were adjusted for diabetes duration, Hypertension age, gender, physical activity, highest level of education, nutrition pattern, dyslipidemia smoking status, alcohol use, use of crack or cocaine, beta blocker, calcium channel blockers, diuretics, Angiotensin converting enzyme inhibitor, Angiotensin Receptor Blocker. Only LVEF, LV FS, MCF and RWT which were additionally controlled for log of BMI